Pediatric Asthma
Pediatric Asthma is a chronic inflammatory disorder of the airways characterized by an obstruction of airflow among children and adolescents aged 5-17 years.

DO I QUALIFY FOR THIS STUDY?

​THE CFOR258 study

Eligible patients: Are 12 years of age or older
Have had an asthma diagnosis for at least one year.
​
Are currently taking medicine to treat their asthma
​
Have experienced exacerbation of asthma symptoms within the past year. 

Study design
A 12-Week, Double-Blind, Randomized, Parallel-Group, Multicenter Study Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25ug, 2 Actuations Twice Daily, and Symbicort pMDI 80/4.5ug, 2 Actuations Twice Daily, Compared with Budesonide pMDI 80ug, Actuations Twice Daily, in Children Ages 6 to 12 Years with Asthma.